tradingkey.logo
tradingkey.logo
Pesquisar

Codexis Inc

CDXS
Adicionar à lista de desejos
2.470USD
+0.080+3.35%
Fechamento 07/02, 13:00ETCotações atrasadas em 15 min
222.99MValor de mercado
PerdaP/L TTM

Mais detalhes de Codexis Inc Empresa

Codexis, Inc. is a provider of enzymatic solutions. It is leveraging its CodeEvolver technology platform to discover, develop, enhance, and commercialize novel, high-performance enzymes and other classes of proteins. The Company utilizes its CodeEvolver technology platform to develop optimized enzymes that are used by some pharmaceutical companies to reduce their costs and improve the efficiency and productivity of their manufacturing processes for small molecule therapeutics. It is developing its Enzyme-Catalyzed Oligonucleotide Synthesis (ECO Synthesis) manufacturing platform to enable the scaled manufacture of RNA interference (RNAi) and other RNA-based therapeutics through an enzymatic route. The Company also uses the CodeEvolver platform technology to develop enzymes for the synthesis of RNAi therapeutics through its ECO Synthesis manufacturing platform, where its enzymes are poised to deliver many of the same benefits it offers in pharmaceutical manufacturing.

Informações de Codexis Inc

Código da empresaCDXS
Nome da EmpresaCodexis Inc
Data de listagemApr 22, 2010
CEOMoore (Alison)
Número de funcionários188
Tipo de títulosOrdinary Share
Fim do ano fiscalApr 22
Endereço200 Penobscot Dr
CidadeREDWOOD CITY
Bolsa de valoresNASDAQ OMX - NASDAQ BASIC
PaísUnited States of America
Código postal94063
Telefone16504218100
Sitehttps://www.codexis.com/
Código da empresaCDXS
Data de listagemApr 22, 2010
CEOMoore (Alison)

Executivos da empresa Codexis Inc

Nome
Nome/Posição
Posição
Ações detidas
Variação
Dr. Alison Moore, Ph.D.
Dr. Alison Moore, Ph.D.
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
250.51K
+30.69%
Mr. David V. Smith
Mr. David V. Smith
Lead Independent Director
Lead Independent Director
194.28K
--
Mr. Kevin Norrett
Mr. Kevin Norrett
Chief Operating Officer
Chief Operating Officer
160.27K
+9.69%
Mr. Dennis P. Wolf
Mr. Dennis P. Wolf
Independent Director
Independent Director
138.95K
-6.44%
Dr. Rahul Singhvi
Dr. Rahul Singhvi
Independent Director
Independent Director
137.05K
+3.65%
Dr. Esther Martinborough, Ph.D.
Dr. Esther Martinborough, Ph.D.
Independent Director
Independent Director
129.04K
--
Ms. Cynthia Collins
Ms. Cynthia Collins
Independent Director
Independent Director
112.16K
--
Mr. Christos Richards
Mr. Christos Richards
Independent Director
Independent Director
85.13K
--
Dr. Raymond De Vre, Ph.D.
Dr. Raymond De Vre, Ph.D.
Independent Director
Independent Director
84.81K
-3.07%
Ms. Georgia L. Erbez
Ms. Georgia L. Erbez
Chief Financial Officer
Chief Financial Officer
66.81K
--
Ver Mais
Nome
Nome/Posição
Posição
Ações detidas
Variação
Dr. Alison Moore, Ph.D.
Dr. Alison Moore, Ph.D.
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
250.51K
+30.69%
Mr. David V. Smith
Mr. David V. Smith
Lead Independent Director
Lead Independent Director
194.28K
--
Mr. Kevin Norrett
Mr. Kevin Norrett
Chief Operating Officer
Chief Operating Officer
160.27K
+9.69%
Mr. Dennis P. Wolf
Mr. Dennis P. Wolf
Independent Director
Independent Director
138.95K
-6.44%
Dr. Rahul Singhvi
Dr. Rahul Singhvi
Independent Director
Independent Director
137.05K
+3.65%
Dr. Esther Martinborough, Ph.D.
Dr. Esther Martinborough, Ph.D.
Independent Director
Independent Director
129.04K
--

Perguntas frequentes

Quem são os cinco principais acionistas de Codexis Inc?

Os cinco principais acionistas de Codexis Inc são: Dr. Alison Moore, Ph.D.

Quantas instituições possuem ações da Codexis Inc (CDXS)?

Em 2026Q1, 273 instituições possuíam ações da Codexis Inc, com valor de mercado aproximado de 66.34M, representando 73.00% do total de ações. Em comparação com 2025Q4, a participação institucional aumentou em -13883230.00.